Edoxaban Impurity 110 | CAS 929693-31-2 - Request Quote
Edoxaban Impurity 110
| SZ CAT No: | SZ-E041132 |
| CAS No | 929693-31-2 |
| Mol.F. | C15H28N2O6S |
| Mol.Wt. | 364.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 110 is chemically (1R,2R,4S)-2-((tert-butoxycarbonyl)amino)-4-(dimethylcarbamoyl)cyclohexyl methanesulfonate. Edoxaban Impurity 110 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 110 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 929693-31-2
Purchase 929693-31-2
Order 929693-31-2
Enquire 929693-31-2
price of 929693-31-2
929693-31-2 Supplier
929693-31-2 Manufacturer
929693-31-2 Exporter
buy high quality Edoxaban Impurity 110
Purchase Edoxaban Impurity 110
Edoxaban Impurity 110 suppliers
Edoxaban Impurity 110 manufacturers
Edoxaban Impurity 110 price
Order Edoxaban Impurity 110
Enquire Edoxaban Impurity 110
Edoxaban Impurity 110 cost
Edoxaban Impurity 110 Supplier
Edoxaban Impurity 110 Distributor
Edoxaban Impurity 110 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 110 for ANDA Filing
Edoxaban Impurity 110 for Forced Degradation Studies
Edoxaban Impurity 110 Identification Standards
Edoxaban Impurity 110 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.